Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page
- Check2 days agoChange DetectedThe study timeline on the page has been updated with new milestone dates: the last update is now 2026-09-09 and the primary completion is 2030-05-30. Related QC update dates (2026-09-07 and 2026-09) have also been added, refining the documented milestones.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe displayed revision number was updated from v3.6.5 to v3.6.6, reflecting a software update to the page. This change does not alter the study information or content visible to users.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe revision label changed from v3.6.4 to v3.6.5, signaling a new version of the page. This represents a backend version update rather than a user-facing content modification.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a new version of the page. This update does not modify the displayed study details or other visible content.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor version update to the page. No substantive study content changes are introduced.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing v3.6.0. This indicates a minor platform update and does not alter study details or participant information.SummaryDifference0.0%

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.